Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2‐weighted, dynamic contrast‐enhanced and diffusion‐weighted imaging
暂无分享,去创建一个
François Cornud | Frédéric Beuvon | F. Beuvon | M. Rouanne | F. Cornud | M. Zerbib | N. Delongchamps | Thierry Flam | Marc Zerbib | T. Flam | Mathieu Rouanne | Nicolas Barry Delongchamps | Mathieu Liberatore | M. Liberatore
[1] Katarzyna J Macura,et al. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. , 2009, Radiology.
[2] G. Haas,et al. Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer , 2009, BJU international.
[3] Tristan Barrett,et al. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. , 2007, AJR. American journal of roentgenology.
[4] L. Turnbull,et al. Description of magnetic resonance imaging‐derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions , 2009, BJU international.
[5] [Quantitative dynamic MRI and localisation of non-palpable prostate cancer]. , 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.
[6] A. Evans,et al. Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[7] A S Whittemore,et al. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.
[8] Deanna L Langer,et al. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. , 2008, Radiology.
[9] L. Chauveinc,et al. IRM dynamique quantitative et localisation du cancer de prostate non palpable , 2009 .
[10] Fernando J. Kim,et al. Combined T 2-weighted and diffusion-weighted MRI for localization of prostate cancer , 2007 .
[11] H. Weinmann,et al. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.
[12] A. Villers,et al. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. , 2006, The Journal of urology.
[13] Xavier Leroy,et al. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. , 2009, Urology.
[14] Evis Sala,et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. , 2006, Radiology.
[15] J H Ellis,et al. MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis. , 1994, AJR. American journal of roentgenology.
[16] Jun Nakashima,et al. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. , 2004, Urology.
[17] L. Egevad,et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.
[18] Masoom A Haider,et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. , 2007, AJR. American journal of roentgenology.
[19] H. Shinmoto,et al. Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging , 2007, Journal of magnetic resonance imaging : JMRI.
[20] M. Reiser,et al. Per-sextant localization and staging of prostate cancer: correlation of imaging findings with whole-mount step section histopathology. , 2007, AJR. American journal of roentgenology.
[21] H. Hricak,et al. Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI. , 2010, Urology.
[22] H. Schlemmer,et al. Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? , 2004, European Radiology.
[23] M. Sumura,et al. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer , 2008, Acta radiologica.
[24] Yuri Kitamura,et al. Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone. , 2006, AJR. American journal of roentgenology.
[25] A. Lopez‐Beltran,et al. 2005 update on pathology of prostate biopsies with cancer. , 2006, European urology.
[26] P. Stattin,et al. Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment. , 2005, European urology.
[27] John Kurhanewicz,et al. Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. , 2008, Magnetic resonance imaging.
[28] E A Zerhouni,et al. Nonpalpable prostate cancer: detection with MR imaging. , 1991, Radiology.
[29] Silvia D. Chang,et al. Combined diffusion‐weighted and dynamic contrast‐enhanced MRI for prostate cancer diagnosis—Correlation with biopsy and histopathology , 2006, Journal of magnetic resonance imaging : JMRI.
[30] K. Taari,et al. Magnetic resonance imaging of clinically localized prostatic cancer. , 1998, The Journal of urology.
[31] T. Stamey,et al. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. , 2000, The Journal of urology.
[32] Henkjan J Huisman,et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. , 2003, Radiology.
[33] Olivier Rouvière,et al. Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? , 2007, European Radiology.